Results 11 to 20 of about 29,864 (215)

Intravenous thrombolysis and platelet count [PDF]

Neurology, 2018
In the article “Intravenous thrombolysis and platelet count” by Gensicke et al.,1 there were a …
Gensicke, H, Al Sultan, AS, Strbian, D, Hametner, C, Zinkstok, SM, Moulin, S, Bill, O, Zini, A, Padjen, V, Kagi, G, Pezzini, A, Seiffge, DJ, Traenka, C, Raty, S, Amiri, H, Zonneveld, TP, Lachenmeier, R, Polymeris, A, Roos, YB, Gumbinger, C, Jovanovic, DR, Curtze, S, Sibolt, G, Vandelli, L, Ringleb, PA, Leys, D, Cordonnier, C, Michel, P, Lyrer, PA, Peters, N, Tatlisumak, T, Nederkoorn, PJ, Engelter, ST   +32 more
openaire   +8 more sources

Intravenous Thrombolysis for a Stroke Mimic Patient [PDF]

Case Reports in Neurology, 2021
The authors present the case of a young woman on phentermine and herbal supplements who presented as an acute stroke alert with right-sided facial droop and numbness. She was treated acutely with intravenous tissue plasminogen activator (tPA). However, the workup did not reveal any evidence of cerebrovascular disease or cerebral infarct.
Lilly Nguyen, Joyce Hoonsuh Lee, Latha Ganti, Mark Rivera-Morales, Larissa Dub   +4 more
openaire   +3 more sources

Comparison of Regional Lepomeningeal Collateral Score and Tan Collateral Score in prediction of prognosis of anterior ischemic stroke with intravenous thrombolysis

Chinese Journal of Contemporary Neurology and Neurosurgery, 2018
Objective To screen the related influencing factors of prognosis in acute anterior ischemic stroke patients who underwent intravenous thrombolysis, and to explore the predictive ability of two collateral scores based on CT angiography (CTA).
Yan CHEN, Jia-ju ZHAO, Bo WU
doaj   +1 more source

Repeated intravenous thrombolysis in early recurrent stroke secondary to carotid web: Case report

Radiology Case Reports, 2021
Intravenous thrombolysis with recombinant tissue plasminogen activator (rt-PA) is the first effective approved treatment for reducing ischemic stroke disability, and having a stroke within 3 months is usually a contraindication to thrombolysis.
Siham Bouchal, PhD, Youssef Alaoui Lamrani, PhD, Naima Chtaou, PhD, Mustafa Maaroufi, PhD, Faouzi Belahsen, PhD   +4 more
doaj   +1 more source

The Clinical Effectiveness of Intra-Arterial versus Intravenous Thrombolysis on the Treatment of Patients with Acute Stroke: A Systematic Review and Meta-Analysis in Clinical Evidence

Health Technology Assessment in Action, 2017
Context: Application of anti-clot drugs such as recombinant tissue plasminogen activator (rt-PA) to treat patients with strokes is considered as a standard treatment employed through two techniques: intra-arterial and intravenous thrombolysis.
Mojtaba Nouhi, Saber Azami, Reza Jahangiri, Moharam Ali Rostami, Yoones Hosseinzadeh Roknabady   +4 more
doaj   +1 more source

Gait and Balance Disorder in Patients with Transient Ischemic Attack or Minor Stroke [Corrigendum]

Neuropsychiatric Disease and Treatment, 2022
Li N, Li J, Gao T, Wang D, Du Y, Zhao X. Neuropsychiatr Dis Treat. 2021;17:305–314. The authors have advised that the r value of intravenous thrombolysis in correlation with the Tandem scale in Table 4 and Table S2 is incorrect.
Li N, Li J, Gao T, Wang D, Du Y, Zhao X
doaj  

Intravenous Thrombolysis in Nonagenarians With Ischemic Stroke [PDF]

Stroke, 2011
Background and Purpose— Demographic changes will result in a rapid increase of patients age ≥90 years (nonagenarians), but little is known about outcomes in these patients after intravenous thrombolysis (IVT) for acute ischemic stroke.
Sarikaya, Hakan, Arnold, Marcel, Engelter, Stefan T., Lyrer, Philippe A., Michel, Patrik, Odier, Céline, Weder, Bruno, Tettenborn, Barbara, Mueller, Felix, Sekoranja, Lucka, Sztajzel, Roman, Ballinari, Pietro, Mattle, Heinrich P., Baumgartner, Ralf W.   +13 more
openaire   +5 more sources

Intracerebral hemorrhage after intravenous thrombolysis in patients with cerebral microbleeds and cardiac myxoma

Frontiers in Neurology, 2014
Background and Purpose: Cardiac myxoma is a rare etiology of stroke. Both cerebral microbleeds and cardiac myxoma may increase the risk of intracerebral hemorrhage after intravenous thrombolysis. However, data is still limited.
Aurauma eChutinet, Aurauma eChutinet, Duangnapa eRoongpiboonsopit, Duangnapa eRoongpiboonsopit, Duangnapa eRoongpiboonsopit, Nijasri C Suwanwela, Nijasri C Suwanwela   +6 more
doaj   +1 more source

Time cost of a nonclosing intravenous thrombolysis service for acute ischemic stroke

Journal of the Formosan Medical Association, 2015
Background/Purpose: Intravenous thrombolysis for ischemic stroke saves societal costs. The aim of this study was to investigate the cost burden that hospitals may shoulder.
Mu-Chien Sun, Pi-Ju Hsiao
doaj   +1 more source

DECOMPRESSIVE HEMICRANIECTOMY AFTER UNSUCCESSFUL INTRAVENOUS THROMBOLYSIS OF MALIGNANT MIDDLE CEREBRAL ARTERY INFARCTION: A CASE REPORT

Паёми Сино, 2023
Objective: The gold standard treatment for patients with cerebral infarction (CI) is intravenous thrombolysis, and it is superior to standard therapy in improving functional status.
S.M. SEHWEIL
doaj   +1 more source